psychotic-disorders

Documents about psychotic-disorders

• A remote and avatar-based approach for social cognitive impairments in psychotic disorders: A Canadian adaptation of RC2S.#823439NCBI PubMed Central
• Adult Study Oxytocin - Behavioral#842274ClinicalTrials.gov
• A Quantitative Analysis of a Reddit-based AI Psychosis Qualitative Dataset#134385OSF
• The Emperor's New Diagnoses: Psychedelics, Psychosis, and the Limits of Psychiatric Distinctions#265819OSF
• Predictors of Beliefs About Medicines in Patients with Psychotic Disorders - A Longitudinal Observational Study in Mental Health Services.#461462NCBI PubMed Central
• Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia#837028ClinicalTrials.gov
• A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis#884975ClinicalTrials.gov
• Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis#902947ClinicalTrials.gov
• Educating medical and nursing students to provide mental health, neurological and substance use care: a practical guide for pre-service education#132016WHO IRIS
• Dissociable contributions of working memory capacity and lapses of attention to cognitive deficits in schizophrenia#154983OSF
• Factors that affect pathways to care for youth with psychotic disorders in Newfoundland and Labrador, Canada: A qualitative study.#189916NCBI PubMed Central
• Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial#849519ClinicalTrials.gov
• Thinking Skills at Work: Cognitive Remediation Therapy for Patients With Serious Mental Illness#873427ClinicalTrials.gov
• A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia#1008402ClinicalTrials.gov
• Digital Delusion: A Mixed Methods Exploration of AI Psychosis in Reddit Posts#134386OSF
• Longitudinal real-world treatment and hospitalisation dynamics in relation to genetic liability across primary psychotic disorders and bipolar disorder#657310bioRxiv / medRxiv
• Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize...#859266ClinicalTrials.gov
• A Registry of Treatment Adherence for Patients With Schizophrenia#872264ClinicalTrials.gov
• Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia#886368ClinicalTrials.gov
• Monitoring and Management for Metabolic Side Effects of Antipsychotics#981255ClinicalTrials.gov
• Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting#981519ClinicalTrials.gov
• Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)#1031735ClinicalTrials.gov
• Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)#812599ClinicalTrials.gov
• Cerebrovascular reactivity mapping using resting-state BOLD-fMRI in individuals with first episode psychosis#263583OSF
• Selective Serotonin Reuptake Inhibitor Treatment in Adolescence and Subsequent Risk of Nonaffective Psychosis: A Quasi-Experimental Study#475794Europe PMC
• Predicting psychological recovery following cognitive-behavioural therapy for psychosis in a naturalistic sample: a machine learning approach#637631OSF
• Critical Time Intervention-Peer Support#828176ClinicalTrials.gov
• The feasibility of resistance training versus aerobic exercise in a rehabilitation setting for people living with psychotic disorders: A randomised controlled trial.#219106NCBI PubMed Central
• Blunted experience of pleasure, unsystematic subjective value representation, and disrupted goal-directed behaviors: an ecological momentary assessment study across mood and psychotic disorders.#265240NCBI PubMed Central
• Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis#806857ClinicalTrials.gov
• RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations#860399ClinicalTrials.gov
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis#846763ClinicalTrials.gov
• Systematic review and meta-analysis of psychosis-like visual perceptual disturbances and visual distortions in real and virtual environments#255914OSF
• The Personalized Psychological Treatment for Psychosis#902656ClinicalTrials.gov
• What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis?#918485ClinicalTrials.gov
• Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)#993184ClinicalTrials.gov
• EEG Predictors of Transition from Clinical High Risk to Psychotic Disorders: A Systematic Review with Implications for Data Harmonisation#295818OSF
• Evaluating a Dialogically-Informed Family Intervention Pathway in Early Intervention for Psychosis: Service User and Carer Experiences#462496OSF
• 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals#908210ClinicalTrials.gov
• Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity#1031342ClinicalTrials.gov
• Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI#812045ClinicalTrials.gov
• Smoking Cessation for Veterans With Severe and Persistent Mental Illness#893838ClinicalTrials.gov
• Berberine as Adjuvant Treatment for Schizophrenia Patients#906882ClinicalTrials.gov
• Psychotic experiences and disorders in adolescents and young adults with borderline intellectual functioning and intellectual disabilities: evidence from a population-based birth cohort in the United Kingdom.#185974NCBI PubMed Central
• Intervenções de enfermagem em saúde mental durante o puerpério: uma revisão integrativa#646846Repositório Institucional da Universidade Federal de Sergipe
• Mobile Self-Tracking of Mental Health#849608ClinicalTrials.gov
• Participatory Video as a Recovery-Oriented Intervention in Early Psychosis#884334ClinicalTrials.gov
• Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement#895736ClinicalTrials.gov
• Évaluatiοn de la symptοmatοlοgie négative dans les trοubles psychοtiques : pertinence de l’utilisatiοn des οutils d’autο-évaluatiοn#171577HAL (France)
• Improving Social Functioning in Youth at Clinical High Risk for Psychotic Disorders With a Virtual Reality Based Cognitive Behavioural Therapy: The Feasibility and Acceptability of REVIVE.#358539NCBI PubMed Central